About Cell Microsystems
Cell Microsystems is a private company based in Durham, North Carolina, incorporated in 2021 in Delaware. It has reported $21,016,164 raised in three offerings on Form D since June 2019. Its chief executive is Gary Pace.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 11, 2023 | Aug 28, 2023 | $6,500,000of $13.0M target | 1 | $6.5M | EquityRule 506(b) | Form D ↗ |
| Nov 8, 2021 | Nov 15, 2021 | $12,666,164of $12.6M target | 17 | $745K | EquityRule 506(b) | Form D ↗ |
| Jun 12, 2019 | Jun 27, 2019 | $1,850,000of $2.2M target | 12 | $154K | DebtRule 506(b) | Form D ↗ |
| Total, three offerings | $21,016,164 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cell Microsystems's Form D filed Aug 28, 2023.
RC
GP
Gary Pace
President and CEO, director
CS
Christopher Sims
Executive officer and director
AH
DL
BW
Brett Williams
Director
Earlier filings also listed Yuli Wang (director, last listed Jun 2019), Nancy Allbritton (director, last listed Jun 2019) and Matthew Megaro (director, last listed Jun 2019).